Information Links
Mims
Main Navigation
Drugs
Conditions
ArticlesRespiratory news
Fluticasone/formoterol asthma combination available in new device
Flutiform K-haler (fluticasone/formoterol) is a new...
Inhalers, a Guide to Breath-Actuated Devices
Key features of dry powder and aerosol inhalers.
MIMS Respiratory and Allergy Learning workshops 2018 - chair announced
Book your free place for a respiratory and allergy...
New corticosteroid MDI option for asthma patients
Kelhale is a new metered-dose beclometasone inhaler...
Asthma and COPD Preparations and Compatible Devices
Available presentations of bronchodilators and anti-inflammatories.
New salmeterol/fluticasone inhaler for adult and childhood asthma
The new pressurised metered-dose inhaler (MDI) Combisal...
Pressurised metered dose inhalers: MHRA warns of cap inhalation risk
Reports of inhaler mouthpiece covers being accidentally...
One week of steroids 'as effective as two weeks' for severe COPD
A shorter course of steroids lasting 3 to 7 days appears...
Long-acting anticholinergic licensed for childhood asthma
Spiriva Respimat (tiotropium) is now licensed for use...
MIMS Respiratory and Allergy Learning workshops 2018 - new Glasgow date announced
A free full-day MIMS workshop in Glasgow has just been...
Capsule inhalation warning for tiotropium inhaler
Train patients prescribed Braltus (tiotropium) in the...
MIMS Respiratory and Allergy Learning workshops 2018 - new Liverpool date announced
A free full-day MIMS workshop in Liverpool has just...
Three-quarters of COPD cases linked to childhood risk factors
Chronic obstructive pulmonary disease (COPD) frequently...
SMART therapy linked to better asthma outcomes
Single maintenance and reliever therapy (SMART) is...
Increasing inhaled steroid doses may not prevent asthma exacerbations in children
Children with mild to moderate asthma do not benefit...
MIMS Respiratory and Allergy Learning workshops 2018 - new Birmingham date announced
A free full-day MIMS workshop in Birmingham has just...
New biologic for severe eosinophilic asthma
Benralizumab (Fasenra) is the latest biologic to be...
Quadrupling steroid dose reduces risk of asthma exacerbations
Temporarily increasing the inhaled glucocorticoid dose...
New MIMS workshop announced launching the 2018 'Respiratory and Allergy Learning Series'
A free full-day MIMS workshop has just been launched...
New once-daily triple combination inhaler for COPD
Trelegy Ellipta is the second 3-in-1 treatment for...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
